TESARO Announces First-Quarter 2018 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil falls as Trump comments on Iran talks ease supply fears
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Powerful quake hits Panama, damages homes; canal operations normal
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Tesaro (TSRO) PT Lowered to $46 at RBC Capital
May 4, 2018 8:53 AM EDTRBC Capital lowered its price target on Tesaro (NASDAQ: TSRO) to $46.00 (from $48.00) while maintaining a Sector Perform rating.
... MoreTesaro (TSRO) PT Lowered to $71 at Evercore ISI
May 4, 2018 7:50 AM EDTEvercore ISI lowered its price target on Tesaro (NASDAQ: TSRO) to $71.00 (from $78.00) while maintaining a Outperform rating based on modest outer year revenue revisions.
... MoreTesaro (TSRO) PT Lowered to $60 at Baird
May 4, 2018 7:48 AM EDTBaird lowered its price target on Tesaro (NASDAQ: TSRO) to $60.00 (from $65.00) while maintaining a Neutral rating following Q1 results.
Analyst Michael Ulz commented, "Zejula sales of $49M in 1Q18 were in line with guidance ($45-50M) and, not surprisingly, modest... More
TESARO (TSRO) Misses Q1 EPS by 28c
May 3, 2018 4:18 PM EDTTESARO (NASDAQ: TSRO) reported Q1 EPS of ($2.98), $0.28 worse than the analyst estimate of ($2.70). Revenue for the quarter came in at $50.2 million versus the consensus estimate of $56.93 million.
ZEJULA Q1 net sales totaled $49 millionEnrollment completed in Phase 3 PRIMA first-line ovarian cancer monotherapy trialTOPACIO... More


